logo-loader
viewCommodities Wrap

Gold climbs 0.7% as investors avert risk; WTI crude settles up 4.5%

gold_ounce350_551463d6898e5.jpg

Gold futures rallied past $1,200 an ounce today to settle at their highest level since early March as investors backed away from riskier assets amid a selloff for global equities and increased tension in the Middle East.

Gold for April delivery climbed 0.7% to settle at $1,204.80 an ounce on Comex. Prices have now climbed for seven sessions in a row, tallying a total gain of 4.9 percent during their streak of gains.

Saudi Arabia and its allies conducted air strikes in Yemen that fuelled worries Middle East energy shipments may be put at risk.

In other metals trading, May silver added 0.8 percent to end at $17.14 an ounce.

May copper rose 0.1 percent to $2.811 a pound.

April platinum tacked on 0.7 percent to $1,154 an ounce and June palladium rose 1 percent to $773.35 an ounce.

In energy trading, oil futures rallied today to tally a fifth straight session of gains as airstrikes in Yemen continued to boost concerns over crude supplies in the Middle East.

West Texas Intermediate for May delivery settled at $51.43 a barrel, up 4.5 percent on the New York Mercantile Exchange.

 

 

 

 

 

Quick facts: Commodities Wrap

Price: - -

TSX-V:S500
Market: TSX-V
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: TRACON Pharmaceuticals reveals its low-cost drug development...

TRACON Pharmaceuticals (NASDAQ:TCON) CEO Charles Theuer tells Proactive the biotechnology company ended 2019 with cash, cash equivalents and short-term investments of $16.4 million. Theuer explains despite engaging in five different clinical trials, three of the five company's clinical trials...

8 hours, 38 minutes ago

2 min read